{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T08:04:33Z","timestamp":1726473873888},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.ejpb.2010.11.013","type":"journal-article","created":{"date-parts":[[2010,12,4]],"date-time":"2010-12-04T04:41:09Z","timestamp":1291437669000},"page":"207-215","source":"Crossref","is-referenced-by-count":12,"title":["Preclinical evaluation of tacrolimus colloidal dispersion for inhalation"],"prefix":"10.1016","volume":"77","author":[{"given":"Alan B.","family":"Watts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay I.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"Talbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin P.","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline J.","family":"Coalson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Robert O.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ejpb.2010.11.013_b0005","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.healun.2008.07.018","article-title":"Registry of the international society for heart and lung transplantation: twenty-fifth official adult lung and heart\/lung transplantation report-2008","volume":"27","author":"Christie","year":"2008","journal-title":"J. Heart Lung Transplant."},{"issue":"5","key":"10.1016\/j.ejpb.2010.11.013_b0010","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1164\/ajrccm.162.5.2003137","article-title":"Pulmonary immunobiology and inflammation in pulmonary diseases","volume":"162","author":"Crapo","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejpb.2010.11.013_b0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1183\/09031936.03.00039203","article-title":"Immunosuppressive therapy after human lung transplantation","volume":"23","author":"Knoop","year":"2004","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.ejpb.2010.11.013_b0020","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1089\/jam.2007.0626","article-title":"Preclincial safety evaluation of inhaled cyclosporine in propylene glycol","volume":"20","author":"Wang","year":"2007","journal-title":"J. Aerosol Med."},{"issue":"2","key":"10.1016\/j.ejpb.2010.11.013_b0025","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0022-5223(97)70331-3","article-title":"Treatment of refractory acute allograft rejection with aerosolized cyclosporine in lung transplant recipients","volume":"113","author":"Keenan","year":"1997","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ejpb.2010.11.013_b0030","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1183\/09031936.04.00058504","article-title":"Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans","volume":"23","author":"Iacono","year":"2004","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.ejpb.2010.11.013_b0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJMoa043204","article-title":"A randomized trial of inhaled cyclosporine in lung-transplant recipients","volume":"354","author":"Iacono","year":"2006","journal-title":"New Engl. J. Med."},{"issue":"9\u201310","key":"10.1016\/j.ejpb.2010.11.013_b0040","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.addr.2006.07.016","article-title":"Inhaled delivery of aerosolized cyclosporine","volume":"58","author":"Corcoran","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2010.11.013_b0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1164\/ajrccm.161.1.9812094","article-title":"Lung delivery of aerosolized dextran","volume":"161","author":"Finlay","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.ejpb.2010.11.013_b0050","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.7164\/antibiotics.40.1256","article-title":"FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro","volume":"40","author":"Kino","year":"1987","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"3","key":"10.1016\/j.ejpb.2010.11.013_b0055","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/0003-4975(95)00407-C","article-title":"Clinical trial of tacrolimus versus cyclosporine in lung transplantation","volume":"60","author":"Keenan","year":"1995","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.ejpb.2010.11.013_b0060","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0041-1345(96)00381-8","article-title":"Long-term renal and pancreas function with tacrolimus rescue therapy following kidney\/pancreas transplantation","volume":"29","author":"Hariharan","year":"1997","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ejpb.2010.11.013_b0065","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(02)11196-2","article-title":"Tacrolimus versus microemulsified ciclosproin in liver transplantation: the TMC randomised controlled trial","volume":"360","author":"O\u2019Grady","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ejpb.2010.11.013_b0070","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/S0041-1345(02)02964-0","article-title":"A cost-effectiveness analysis of tacrolimus versus cyclosporine microemulsion following kidney transplantation","volume":"34","author":"Craig","year":"2002","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ejpb.2010.11.013_b0075","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1081-1206(10)62297-1","article-title":"Tacrolimus inhibits cytokine production and chemical mediator release following antigen stimulation of passively sensitized human lung tissues","volume":"86","author":"Matsuo","year":"2001","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"5p2","key":"10.1016\/j.ejpb.2010.11.013_b0080","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1600-6143.2006.01270.x","article-title":"Immunosuppression: evolution in practice and trends, 1994\u20132004","volume":"6","author":"Meier-Kriesche","year":"2006","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.ejpb.2010.11.013_b0085","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/00007890-200208270-00024","article-title":"Neurotoxicity induced by tacrolimus after liver transplantation: relation to genetic polymorphisms of the ABCB1 (MDR1) gene","volume":"74","author":"Yamauchi","year":"2002","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.ejpb.2010.11.013_b0090","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1600-6143.2003.00372.x","article-title":"New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis","volume":"4","author":"Heisel","year":"2004","journal-title":"Am. J. Transplant."},{"issue":"12","key":"10.1016\/j.ejpb.2010.11.013_b0095","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2165\/00003495-200363120-00006","article-title":"Tacrolimus: a further update of its use in the management of organ transplantation","volume":"63","author":"Scott","year":"2003","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.ejpb.2010.11.013_b0100","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.ejpb.2008.01.037","article-title":"Nebulization of nanoparticulate amorphous or crystalline tacrolimus \u2013 single-dose pharmacokinetics study in mice","volume":"69","author":"Sinswat","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.ejpb.2010.11.013_b0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejpb.2006.07.012","article-title":"Novel ultra-rapid freezing particle engineering process for enhancement of dissolution rates of poorly water-soluble drugs","volume":"65","author":"Overhoff","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2010.11.013_b0110","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0378-5173(03)00091-7","article-title":"A novel method for assessing dissolution of aerosol inhaler products","volume":"255","author":"Davies","year":"2003","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2010.11.013_b0115","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jconrel.2005.01.003","article-title":"Novel sustained release microspheres for pulmonary drug delivery","volume":"104","author":"Cook","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2010.11.013_b0120","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0731-7085(95)01605-8","article-title":"Quantitative determination of tautomeric FK506 by reversed-phase liquid chromatography","volume":"14","author":"Akashi","year":"1996","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2010.11.013_b0125","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijpharm.2009.09.040","article-title":"Characterization and pharmacokinetic analysis of tacrolimus dispersion for nebulization in a transplanted rodent model","volume":"384","author":"Watts","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2010.11.013_b0130","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1348-0421.1992.tb02045.x","article-title":"Definition and application of a histopathological scoring scheme for an animal model of acute mycoplasma pneumoniae pulmonary infection","volume":"36","author":"Cimolai","year":"1992","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.ejpb.2010.11.013_b0135","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijpharm.2003.07.010","article-title":"Establishment of new preparation method for solid dispersion formulation of tacrolimus","volume":"267","author":"Yamashita","year":"2003","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ejpb.2010.11.013_b0140","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/10717540701202937","article-title":"Effect of conditions of preparation on the size and encapsulation properties of PLGA-mPEG nanoparticles of cisplatin","volume":"14","author":"Gryparis","year":"2007","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2010.11.013_b0145","unstructured":"ICH, International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Impurities in New Drug Products: Q3B(R2), Geneva, Switzerland, 2006. <http:\/\/www.ich.org\/LOB\/media\/MEDIA421.pdf>."},{"key":"10.1016\/j.ejpb.2010.11.013_b0150","unstructured":"ICH, International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Impurities: Guidelines for Residual Solvents Q3B(R3), Geneva, Switzerland, 2006. <http:\/\/www.ich.org\/LOB\/media\/MEDIA423.pdf>."},{"issue":"5","key":"10.1016\/j.ejpb.2010.11.013_b0155","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0731-7085(03)00377-7","article-title":"Relation between retention factors of immunosuppressive drugs in microemulsion electrokinetic chromatography with biosurfactants and octanol\u2013water partition coefficients","volume":"33","author":"Lucangioli","year":"2003","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.ejpb.2010.11.013_b0160","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1023\/A:1022275222207","article-title":"Lung deposition and pharmacokinetics of cyclosporine after aerosolization in lung transplant patients","volume":"20","author":"Burckart","year":"2003","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2010.11.013_b0165","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0169-409X(95)00101-C","article-title":"Do interactions with phospholipids contribute to the prolonged retention of polypeptides within the lung?","volume":"19","author":"McAllister","year":"1996","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"30","key":"10.1016\/j.ejpb.2010.11.013_b0170","doi-asserted-by":"crossref","first-page":"9926","DOI":"10.1021\/bi036227z","article-title":"Characterization of liposomal tacrolimus in lung surfactant-like phospholipids and evaluation of its immunosuppressive activity","volume":"43","author":"Canadas","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejpb.2010.11.013_b0175","first-page":"S104","article-title":"Pharmacokinetic assessment of pulmonary absorption and accumulation after inhalation of a cyclosporine derivative, IMM 125","volume":"12","author":"Kawai","year":"1997","journal-title":"Xenobio. Metabol. Dispos."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2010.11.013_b0180","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijpharm.2007.02.014","article-title":"Murine airway histology and intracellular uptake of inhaled amorphous itraconazole","volume":"338","author":"Vaughn","year":"2007","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2010.11.013_b0185","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00441-006-0346-6","article-title":"P-glycoprotein (MDR1) functional activity in human alveolar epithelial cell monolayers","volume":"328","author":"Endter","year":"2007","journal-title":"Cell Tissue Res."},{"issue":"7","key":"10.1016\/j.ejpb.2010.11.013_b0190","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1097\/01.ASN.0000073901.94759.36","article-title":"Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients","volume":"14","author":"Anglicheau","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.ejpb.2010.11.013_b0195","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1600-6143.2005.00870.x","article-title":"Tacrolimus pharmacokinetics and dose monitoring after lung transplantation for cystic fibrosis and other conditions","volume":"5","author":"Knoop","year":"2005","journal-title":"Am. J. Transplant."},{"issue":"6","key":"10.1016\/j.ejpb.2010.11.013_b0200","first-page":"2997","article-title":"Eosinophil infiltration of human colonic carcinomas as a prognostic indicator","volume":"43","author":"Pretlow","year":"1983","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejpb.2010.11.013_b0205","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood.V59.1.157.157","article-title":"Pseudothrombocytopenia: an immunologic study on platelet antibodies dependent on ethylene diamine tetra-acetate","volume":"59","author":"Pegels","year":"1982","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ejpb.2010.11.013_b0210","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00000539-200107000-00026","article-title":"Understanding the mechanisms by which isoflurane modifies the hyperglycemic response to surgery","volume":"93","author":"Lattermann","year":"2001","journal-title":"Anesth. Analg."},{"issue":"1","key":"10.1016\/j.ejpb.2010.11.013_b0215","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10565-005-1781-y","article-title":"Vitamin E protects against acetone-induced oxidative stress in rat red blood cells","volume":"21","author":"Armutcu","year":"2005","journal-title":"Cell Biol. Toxicol."},{"issue":"3","key":"10.1016\/j.ejpb.2010.11.013_b0220","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.vaccine.2005.07.074","article-title":"Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP)","volume":"24","author":"Johnson","year":"2006","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.ejpb.2010.11.013_b0225","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/ndt\/gfh785","article-title":"Reversal of oliguric tacrolimus nephrotoxicity in children","volume":"20","author":"McLaughlin","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.ejpb.2010.11.013_b0230","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1523-1755.2005.00461.x","article-title":"Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot study","volume":"68","author":"Mok","year":"2005","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.ejpb.2010.11.013_b0235","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/0961203306073167","article-title":"A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockade","volume":"16","author":"Tse","year":"2007","journal-title":"Lupus"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2010.11.013_b0240","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.trim.2008.09.002","article-title":"Prevention of calcineurin inhibitor nephrotoxicity in renal transplantation","volume":"20","author":"Jacquet","year":"2008","journal-title":"Transplant. Immunol"},{"key":"10.1016\/j.ejpb.2010.11.013_b0245","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/01.TP.0000128837.07640.AE","article-title":"Acute nephrotoxicity of tacrolimus and sirolimus in renal isografts: differential intragraft expression of transforming growth factor-\u03b21 and \u03b1-smooth muscle actin","volume":"78","author":"Ninova","year":"2004","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.ejpb.2010.11.013_b0250","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/01.TP.0000128636.70499.6E","article-title":"Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology","volume":"78","author":"Nankivell","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.ejpb.2010.11.013_b0255","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1378\/chest.42.3.251","article-title":"Aerosol-induced sputum: an effective inexpensive method for nebulization of a super-heated mixture of 40 per cent propylene glycol in isotonic saline","volume":"42","author":"Johnson","year":"1962","journal-title":"Dis. Chest"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641110003073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641110003073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T05:56:15Z","timestamp":1592114175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641110003073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0939641110003073"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2010.11.013","relation":{},"ISSN":["0939-6411"],"issn-type":[{"type":"print","value":"0939-6411"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}